COVID-19 vaccine generates immune structures critical for lasting immunity
COVID-19 vaccine generates immune structures critical for lasting immunity Vaccines likely induce strong, persistent immunity to COVID-19. The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never been used in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease. Still, concerns remain over how long immunity induced by the new vaccine technology will last. Now, a study from researchers at Washington University School of Medicine in St. Louis, published June 28 in the journal Nature , has found evidence that the immune response to such vaccines is both strong and potentially long-lasting. For example, nearly four months after the first dose, people who received the Pfizer vaccine still had so-called germinal centers in their lymph nodes churning out immune cells directed against SARS-CoV-2, the virus that causes COVID-1...